Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adrenomedullin and PAMP]

K Kitamura1, T Eto

  • 1First Department of Internal Medicine, Miyazaki Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP) are novel hypotensive peptides involved in cardiovascular homeostasis. Their elevated plasma levels in cardiovascular diseases highlight their role in circulation control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperthermo-chemo-radiotherapy as a definitive treatment for patients with early esophageal carcinoma.

American journal of clinical oncology·1992
Same author

A new chemotherapy against pseudomyxoma peritonei.

The American journal of gastroenterology·1992
Same author

Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.

Cancer research·1992
Same author

Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution.

Gastrointestinal endoscopy·1992
Same author

Synergistic effects of intratumor administration of cis-diamminedichloroplatinum(II) combined with local hyperthermia in melanoma bearing mice.

Journal of surgical oncology·1992
Same author

Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites.

The Biochemical journal·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology

Context:

  • Adrenomedullin (AM), a hypotensive peptide, was discovered in human pheochromocytoma.
  • Proadrenomedullin N-terminal 20 peptide (PAMP) is a related hypotensive peptide derived from proadrenomedullin.

Purpose:

  • To review recent advancements in Adrenomedullin (AM) and PAMP research.
  • To elucidate the physiological and pathophysiological roles of AM and PAMP in circulation control.

Summary:

  • AM and PAMP exhibit hypotensive effects in rats through distinct mechanisms.
  • AM mRNA is highly expressed in various tissues, including the adrenal medulla, heart, lungs, kidneys, and aorta.
  • Plasma concentrations of AM and PAMP increase significantly in cardiovascular diseases like hypertension and congestive heart failure.

Related Experiment Videos

Impact:

  • AM and PAMP are identified as crucial vasoactive peptides in cardiovascular regulation.
  • This research provides insights into the mechanisms underlying cardiovascular diseases and potential therapeutic targets.